Parkman Healthcare Partners LLC Horizon Therapeutics Public LTD CO Transaction History

Parkman Healthcare Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $8.71 Million - $11.1 Million	-100,747 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $2.07 Million - $2.52 Million	20,980 Added 26.3%	100,747 $10.9 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $689,325 - $827,775	7,500 Added 10.38%	79,767 $8.74 Million
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $330,902 - $368,045	3,837 Added 5.61%	72,267 $6.77 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $7.71 Million - $10.2 Million	-107,282 Reduced 61.06%	68,430 $6.3 Million
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $4.1 Million - $5.17 Million	-61,242 Reduced 25.85%	175,712 $12.9 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $1.38 Million - $1.99 Million	-24,952 Reduced 9.53%	236,954 $18.4 Million
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $453,000 - $854,700	15,000 Added 6.08%	261,906 $14.6 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $470,888 - $730,095	-18,934 Reduced 7.12%	246,906 $7.31 Million
Q4 2019 Feb 13, 2020	BUY	$25.43 - $36.67 $6.76 Million - $9.75 Million	265,840 New	265,840 $9.62 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.